These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25499664)

  • 1. Investigational new treatments for Clostridium difficile infection.
    Ivarsson ME; Leroux JC; Castagner B
    Drug Discov Today; 2015 May; 20(5):602-8. PubMed ID: 25499664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
    Khoruts A
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapies on the horizon for Clostridium difficile infections.
    McFarland LV
    Expert Opin Investig Drugs; 2016; 25(5):541-55. PubMed ID: 26934513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
    Soriano MM; Liao S; Danziger LH
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.
    Gil F; Paredes-Sabja D
    Future Microbiol; 2016 Sep; 11():1179-89. PubMed ID: 27546386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonantimicrobial drug targets for Clostridium difficile infections.
    Darkoh C; Deaton M; DuPont HL
    Future Microbiol; 2017 Sep; 12(11):975-985. PubMed ID: 28759258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic strategies for Clostridium difficile infections.
    Ünal CM; Steinert M
    Expert Opin Ther Targets; 2016; 20(3):269-85. PubMed ID: 26565670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of Clostridium difficile infection.
    Korman TM
    Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is pediatric Clostridium difficile infection associated with prior antibiotic exposure?
    Kociolek LK; Gerding DN
    Future Microbiol; 2014; 9(7):825-8. PubMed ID: 25156370
    [No Abstract]   [Full Text] [Related]  

  • 10. The contribution of strains and hosts to outcomes in Clostridium difficile infection.
    Martin J
    Infect Dis Clin North Am; 2015 Mar; 29(1):51-61. PubMed ID: 25582645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs and strategies for management of Clostridium difficile colitis.
    Higa JT; Kelly CP
    J Intensive Care Med; 2014; 29(4):190-9. PubMed ID: 23753229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
    Venugopal AA; Johnson S
    Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existing and investigational therapies for the treatment of Clostridium difficile infection: A focus on narrow spectrum, microbiota-sparing agents.
    Maxwell-Scott HG; Goldenberg SD
    Med Mal Infect; 2018 Feb; 48(1):1-9. PubMed ID: 29169816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current developments in lantibiotic discovery for treating Clostridium difficile infection.
    Sandiford SK
    Expert Opin Drug Discov; 2019 Jan; 14(1):71-79. PubMed ID: 30479173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile. A super serious bug.
    Mayo Clin Health Lett; 2012 Apr; 30(4):6. PubMed ID: 22649818
    [No Abstract]   [Full Text] [Related]  

  • 16. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL; Garey K; Caeiro JP; Jiang ZD
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives in Clostridium difficile disease pathogenesis.
    Monaghan TM
    Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Refractory Clostridium difficile infection. Untraditional treatment of antibiotic-induced colitis].
    Fløtterød O; Hopen G
    Tidsskr Nor Laegeforen; 1991 Apr; 111(11):1364-5. PubMed ID: 2042156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies.
    Gil F; Calderón IL; Fuentes JA; Paredes-Sabja D
    Future Microbiol; 2018 Mar; 13():469-482. PubMed ID: 29464969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.